IL33 and T-cell non-Hodgkin lymphoma: However, unlike recombinant IL-33, recombinant GM-CSF did not inhibit tumor growth in the EG7 T-cell lymphoma model (Fig. 2 B) and TC-1 tumor model (Fig. S2A) in TB mice; instead, it promoted tumor growth in the B16F10 tumor model (Fig. S2B).